Cyclerion Therapeutics Inc (NASDAQ:CYCN) dropped 6.2% during mid-day trading on Thursday . The company traded as low as $1.79 and last traded at $1.82, approximately 682,400 shares were traded during mid-day trading. An increase of 152% from the average daily volume of 270,909 shares. The stock had previously closed at $1.94.

The company’s 50 day moving average is $8.00 and its two-hundred day moving average is $10.82. The company has a debt-to-equity ratio of 0.51, a quick ratio of 6.60 and a current ratio of 6.60.

Cyclerion Therapeutics (NASDAQ:CYCN) last posted its earnings results on Monday, August 12th. The company reported ($1.18) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.84) by ($0.34). The company had revenue of $1.63 million for the quarter.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Broderick Brian C purchased a new position in Cyclerion Therapeutics during the third quarter valued at $399,000. California Public Employees Retirement System purchased a new position in Cyclerion Therapeutics during the third quarter valued at $404,000. First Trust Advisors LP purchased a new position in Cyclerion Therapeutics during the third quarter valued at $430,000. Finally, Russell Investments Group Ltd. purchased a new position in Cyclerion Therapeutics during the third quarter valued at $1,112,000. 71.38% of the stock is owned by institutional investors.

Cyclerion Therapeutics Company Profile (NASDAQ:CYCN)

There is no company description available for Cyclerion Therapeutics Inc

Recommended Story: Day Trading

Receive News & Ratings for Cyclerion Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclerion Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.